Evaluating Organ Systems in Lupus
LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.
Anifrolumab for Lupus
Anifrolumab, a type 1 interferon receptor antagonist, performs well in early trial, researchers show.
From Childhood to Adulthood, Lupus Damage Accrues
A longitudinal study of adults with childhood-onset lupus shows that disease damage accrues over the entire disease course.
Glucocorticosteroids Associated with More Disease Damage in Lupus
For systemic lupus erythematosus patients prescribed glucocorticosteroids, mortality has been found to be more frequent than in patients not prescribed glucocorticosteroids, researchers say.
Ped-ANAM, a Promising Assessment Tool for Pediatric Lupus
There are few tests to accurately assess the degree and effects of lupus in children, but Ped-ANAM proves to be a promising option.
Cracks in Healthcare Apparent in Lupus Community
Lupus patients who receive healthcare at more than one location face a greater risk of infection and comorbidities, research shows.
Autoimmune Bullae-Forming Skin Disease Associated with IgE Autoantibodies
Researchers have made an important discovery that may lead to new treatment for patients with bullous pemphigoid, a chronic autoimmune skin disease causing blisters.
By clicking Accept, you agree to become a member of the UBM Medica Community.